Evidence map›Paper›PMID 32839570›Full record

ReviewNature reviews. Immunology2021

Lactate modulation of immune responses in inflammatory versus tumour microenvironments.

Michelangelo Certo, Chin-Hsien Tsai, Valentina Pucino, Ping-Chih Ho, Claudio Mauro

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 538 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
538citing papers in PubMed, 1 pooled it
28.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

538 citing papers in PubMed, 1 synthesis or guideline pooled it, 860 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. CD112 Lactylation Drives Dual Immune Evasion From CD8+ T Cells and NK Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Histone deacetylases in cancer metabolic reprogramming.Experimental & molecular medicine · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

478 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Michelangelo CertoInstitute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-5568-3465
Chin-Hsien TsaiDepartment of Oncology UNIL CHUV, Ludwig Institute for Cancer Research, Lausanne, Switzerland.
Valentina PucinoInstitute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-7683-4568
Ping-Chih HoDepartment of Oncology UNIL CHUV, Ludwig Institute for Cancer Research, Lausanne, Switzerland. ping-chih.ho@unil.ch.ORCID http://orcid.org/0000-0003-3078-3774
Claudio MauroInstitute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. c.mauro@bham.ac.uk.ORCID http://orcid.org/0000-0002-3736-0099
University of Birmingham · GBLudwig Cancer Research · CHLudwig Cancer Research · BE

Funding

British Heart Foundation FS/12/38/29640British Heart Foundation PG/15/105/31906Medical Research Council MR/P021220/1Medical Research Council MR/T016736/1
6 · The paper itself

Abstract

The microenvironment in cancerous tissues is immunosuppressive and pro-tumorigenic, whereas the microenvironment of tissues affected by chronic inflammatory disease is pro-inflammatory and anti-resolution. Despite these opposing immunological states, the metabolic states in the tissue microenvironments of cancer and inflammatory diseases are similar: both are hypoxic, show elevated levels of lactate and other metabolic by-products and have low levels of nutrients. In this Review, we describe how the bioavailability of lactate differs in the microenvironments of tumours and inflammatory diseases compared with normal tissues, thus contributing to the establishment of specific immunological states in disease. A clear understanding of the metabolic signature of tumours and inflammatory diseases will enable therapeutic intervention aimed at resetting the bioavailability of metabolites and correcting the dysregulated immunological state, triggering beneficial cytotoxic, inflammatory responses in tumours and immunosuppressive responses in chronic inflammation.

Indexed as

Biological AvailabilityCarrier ProteinsHumansInflammationLactic AcidL-Lactate DehydrogenaseMembrane ProteinsNeoplasmsThyroid Hormone-Binding ProteinsThyroid HormonesTumor MicroenvironmentCarrier ProteinsLactic AcidL-Lactate DehydrogenaseMembrane ProteinsThyroid Hormone-Binding ProteinsThyroid Hormones

Identifiers

PMID32839570
OpenAlexW3080945733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.